Jacob S. Van Naarden
Chief Business Officer
biotechnology
LOXO GMBH
United States of America
Biography
Jacob S. Van Naarden serves as Chief Business Officer. In his previous roles, Mr. Van Naarden served in various biotechnology investing, operating, and advisory capacities. Previously, Mr. Van Naarden served as a public equity biotechnology analyst at HealthCor Management, a multi-billion dollar healthcare-dedicated investment firm based in NYC. Prior to HealthCor, Mr. Van Naarden was an Associate at Aisling Capital, a multi-strategy healthcare investment firm based in NY. Mr. Van Naarden started his career in the Healthcare Group of the Investment Banking Division at Goldman Sachs. Mr. Van Naarden received his A.B. degree in molecular biology from Princeton University, graduating magna cum laude and Phi Beta Kappa.
Research Interest
biotechnology analyst ,investing, operating, and advisory capacities.